Organon announced that CEO Kevin Ali intends to resign from his position following results from an internal investigation ...
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion ...
GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...
Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...
PE: What makes TrumpRx different from other government-run health programs? O’Dell: TrumpRx is different in that its ...
Biologic age is determined by measuring how well the body’s cells and organs are functioning. This is different than ...
Obesity is a complex, treatable medical condition, not just a matter of willpower, requiring a shift in perception and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback